The results eased investor concerns after UnitedHealth Group flagged a surge in demand for non-urgent surgeries and outpatient services last month.
Continue readingCategory Archives: Uncategorized
Dimon says private equity giants are ‘dancing in the streets’ over tougher bank rules
Banks face requirements to hold more capital as a cushion against risky activities from both U.S. and international regulators.
Continue readingEli Lilly to acquire obesity drug maker Versanis for $1.9 billion
The deal is Eli Lilly’s latest attempt to capitalize on the weight loss industry gold rush, which was sparked by demand for Novo Nordisk’s Wegovy […]
Continue readingFDA says soda sweetener aspartame is safe, disagreeing with WHO finding on possible cancer link
The FDA said the studies that World Health Organization experts relied on to make this conclusion had “significant shortcomings.”
Continue readingAmerican, JetBlue to end sales of each others’ tickets next week after judge orders breakup
American and JetBlue will stop selling each other’s tickets this month after judge orders them to end their Northeast partnership.
Continue readingJPMorgan Chase beats analysts’ estimates on higher rates, interest income
JPMorgan has been a port in the storm for bank investors this year. Its hot streak continued with second-quarter earnings.
Continue readingWHO says soda sweetener aspartame may cause cancer, but it’s safe within limits
The International Agency for Research on Cancer identified a possible link between aspartame and a type of liver cancer called hepatocellular carcinoma.
Continue readingWHO decision on aspartame could hurt diet soda sales or lead to new drink formulas
Coca-Cola, PepsiCo and Keurig Dr Pepper may decide to change their formulas and swap out aspartame for another sweetener.
Continue readingUninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says
Warren said the report shows that Congress needs to take additional steps to reduce the excessive prices of insulin from Eli Lilly, Sanofi and Novo […]
Continue readingBiden administration to provide free Covid vaccines to uninsured Americans this fall through end of 2024
The HHS program aims to maintain broad access to Covid shots and treatments after the federal government shifts those products to the commercial market.
Continue reading